Targeting EphA2 suppresses hepatocellular carcinoma initiation and progression by dual inhibition of JAK1/STAT3 and AKT signaling.

ABSTRACT:

SUBMITTER: Wang H 

PROVIDER: S-EPMC12548290 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature